560P Safety and efficacy of Debio 1143, an antagonist of inhibitor of apoptosis proteins (IAPs), in combination with nivolumab in a phase Ib/II trial in patients (pts) failing prior PD-1/PD-L1 treatment. - Pedrazzoli, A.B. Azaro; Moreno, V.; Gomez-Roca, C.A.; Even, C.; Cassier, P.; Guerrero, T.C. Hernandez; de Miguel, M.; Korakis, I.; Purcea, D.; Roy, E.; Gollmer, K.; Riff, C.; et al. (Annals of Oncology, 2020)